OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OPCH$21.0059

Option Care Health Inc

Healthcare Facilities & ServicesVerified

Option Care Health Inc maintains a market price of $21.00, with a market capitalization of $3.298 billion. The company's price-to-earnings ratio is 15.89, and its price-to-book ratio is 2.49, indicating a moderate valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.53, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, which may pose a liquidity risk. In terms of profitability, Option Care Health Inc has a return on equity of 15.65% and a return on assets of 6.01%. These figures are compared against the industry's preferred metrics, which typically emphasize high return on equity and efficient asset utilization. The company's operating income of $333.2 million and net income of $207.6 million indicate a profitable operation, but the gross profit of $1.088 billion suggests that the company's cost of goods sold is a significant portion of its revenue. The company's revenue is concentrated in its core business of home infusion therapy and specialty pharmacy services, with no significant geographic diversification mentioned in the available data. This concentration may expose the company to risks associated with changes in the healthcare market or regulatory environment. Looking at the growth trajectory, the company's revenue has shown a positive trend, but specific numeric deltas for the current and next fiscal years are not provided. The company's capital expenditure of -$41.3 million indicates a reduction in spending, which may be a strategic move to improve liquidity or focus on core operations. The risk assessment for Option Care Health Inc highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.88 suggests a balanced capital structure, but the negative net cash position after subtracting total debt is a concern. The company has not indicated any dilution potential in the basic shares outstanding, and no adjustments have been applied to the valuation metrics. Recent events and filings have not been detailed in the provided data, so no specific recent developments can be cited. However, the company's financial performance and risk profile suggest that it is a stable player in the healthcare services sector, with a focus on maintaining profitability and managing its capital structure.

30-day price · OPCH-8.00 (-27.7%)
Low$18.01High$29.20Close$20.93As of22 May, 00:00 UTC
Profile
CompanyOption Care Health Inc
TickerOPCH.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Option Care Health Inc provides home infusion therapy and specialty pharmacy services to patients, generating revenue primarily through service fees and medication sales.

Classification. Option Care Health Inc is classified in the Healthcare Facilities & Services industry under the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Option Care Health Inc maintains a market price of $21.00, with a market capitalization of $3.298 billion. The company's price-to-earnings ratio is 15.89, and its price-to-book ratio is 2.49, indicating a moderate valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.53, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, which may pose a liquidity risk. In terms of profitability, Option Care Health Inc has a return on equity of 15.65% and a return on assets of 6.01%. These figures are compared against the industry's preferred metrics, which typically emphasize high return on equity and efficient asset utilization. The company's operating income of $333.2 million and net income of $207.6 million indicate a profitable operation, but the gross profit of $1.088 billion suggests that the company's cost of goods sold is a significant portion of its revenue. The company's revenue is concentrated in its core business of home infusion therapy and specialty pharmacy services, with no significant geographic diversification mentioned in the available data. This concentration may expose the company to risks associated with changes in the healthcare market or regulatory environment. Looking at the growth trajectory, the company's revenue has shown a positive trend, but specific numeric deltas for the current and next fiscal years are not provided. The company's capital expenditure of -$41.3 million indicates a reduction in spending, which may be a strategic move to improve liquidity or focus on core operations. The risk assessment for Option Care Health Inc highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.88 suggests a balanced capital structure, but the negative net cash position after subtracting total debt is a concern. The company has not indicated any dilution potential in the basic shares outstanding, and no adjustments have been applied to the valuation metrics. Recent events and filings have not been detailed in the provided data, so no specific recent developments can be cited. However, the company's financial performance and risk profile suggest that it is a stable player in the healthcare services sector, with a focus on maintaining profitability and managing its capital structure.
Key takeaways
  • Option Care Health Inc has a moderate valuation with a price-to-earnings ratio of 15.89 and a price-to-book ratio of 2.49.
  • The company's profitability is reflected in a return on equity of 15.65% and a return on assets of 6.01%.
  • The company's liquidity position is characterized by a current ratio of 1.53, but it has a negative net cash position after subtracting total debt.
  • The company's revenue is concentrated in its core business of home infusion therapy and specialty pharmacy services.
  • The company's capital expenditure of -$41.3 million indicates a reduction in spending.
  • The risk assessment highlights a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • margin_outlook_rationale: The company's gross profit margin is expected to remain stable due to consistent service fees and medication sales.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.65B
Gross profit$1.09B
Operating income$333.2M
Net income$207.6M
R&D
SG&A
D&A
SBC
Operating cash flow$258.4M
CapEx-$41.3M
Free cash flow$237.0M
Total assets$3.46B
Total liabilities$2.13B
Total equity$1.33B
Cash & equivalents$232.6M
Long-term debt$1.16B
Valuation
Market price$21.00
Market cap$3.30B
Enterprise value$4.23B
P/E15.9
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income12.7
EV/OCF16.4
P/B2.5
P/Tangible book2.5
Tangible book$1.33B
Net cash-$928.2M
Current ratio1.5
Debt/Equity0.9
ROA6.0%
ROE15.7%
Cash conversion1.2%
CapEx/Revenue-0.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricOPCHActivity
Op margin5.9%5.6% medp25 -4.2% · p75 12.6%above median
Net margin3.7%2.8% medp25 -3.4% · p75 8.8%above median
Gross margin19.3%36.5% medp25 23.7% · p75 65.2%bottom quartile
CapEx / revenue-0.7%-4.9% medp25 -11.5% · p75 -2.0%top quartile
Debt / equity88.0%69.3% medp25 7.9% · p75 120.9%above median
Observations
IR observations
Mean price target29.80 USD
Median price target30.00 USD
High price target39.00 USD
Low price target22.00 USD
Mean recommendation1.83 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count6.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.85 USD
Last actual EPS1.72 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 21:24 UTC#9b1e92fd
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 20:59 UTCJob: 46ac1012